CLINICAL_TRIALS
trial_result
· 2014-06-12
Clinical Trial Update: Dipeptidyl Peptidase-4 Inhibitor (Sitagliptin) Therapy in the Inpatients With Type 2 Diabetes [Phase 4]
Summary
Clinical trial update for sitagliptin (DPP-4 inhibitor) in hospitalized patients with type 2 diabetes; Phase 4 completed with results posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Emory University | Conditions: Type 2 Diabetes Mellitus, Hospitalization | Phase 4 | Status: COMPLETED | Results posted: 2014-06-12